Statistics for Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential
Total visits
| views | |
|---|---|
| Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential | 261 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 1 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| 10.pdf | 349 |
| java.util.UUID:facad196-8327-4a48-87bd-477ebd8e56b3 | 48 |
| java.util.UUID:ed891987-6273-4c5e-9750-b535d5a31fb8 | 24 |
| java.util.UUID:629c7a65-2075-4102-a0d9-5575b60295be | 10 |
Top country views
| views | |
|---|---|
| United States | 199 |
| Germany | 11 |
| Sweden | 9 |
| Ukraine | 6 |
| Canada | 3 |
| Russia | 3 |
| China | 2 |
| United Kingdom | 1 |
| India | 1 |
| Lebanon | 1 |
| Malaysia | 1 |
| Netherlands | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 53 |
| Fairfield | 23 |
| Ann Arbor | 15 |
| Houston | 15 |
| Kiez | 9 |
| Stockholm | 8 |
| Cambridge | 7 |
| Jacksonville | 7 |
| White Plains | 7 |
| Kiev | 6 |
| San Francisco | 4 |
| Saint Petersburg | 3 |
| Toronto | 3 |
| Beijing | 2 |
| Brooklyn | 2 |
| Chicago | 2 |
| Concord | 2 |
| Gunzenhausen | 2 |
| Kansas City | 2 |
| Washington | 2 |
| Baltimore | 1 |
| Beirut | 1 |
| Brookline | 1 |
| Champaign | 1 |
| Den Haag | 1 |
| Indianapolis | 1 |
| Lake Mary | 1 |
| Ludhiana | 1 |
| Motala | 1 |
| Overland Park | 1 |
| Philadelphia | 1 |
| Scottsdale | 1 |
| Seremban | 1 |